Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS‐IPS study
M Pagliari, Frits R. Rosendaal, Minoo Ahmadinejad, Zahra Badiee, Mohammad‐Reza Baghaipour, Luciano Baronciani, Olga Benítez, Imre Bodó, Ulrich Budde, Giancarlo Castaman, Peyman Eshghi, Jenny Goudemand, Mehran Karimi, Bijan Keikhaei, Riitta Lassila, Frank W.G. Leebeek, María Fernanda López Fernández, Pier Mannuccio Mannucci, Renato Marino, Johannes Oldenburg, I. R. Peake, Cristina Santoro, Reinhard Schneppenheim, Andreas Tiede, Gholamreza Toogeh, Alberto Tosetto, Marc Trossaërt, Hamideh Yadegari, Eva Zetterberg, Flora Peyvandi, Augusto B. Federici, Jeroen Eikenboom (2022). Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS‐IPS study. Journal of Thrombosis and Haemostasis, 20(5), pp. 1106-1114, DOI: 10.1111/jth.15658.
